Sinoatrial node dysfunction and deafness (SANDD) syndrome is rare and characterized by a low heart beat and severe-toprofound deafness. Additional features include fatigue, dizziness, and episodic syncope. The sinoatrial node (SAN) drives heart automaticity and continuously regulates heart rate. The CACNA1D gene encoding the Ca v 1.3 protein expressed in inner hair cells, atria and SAN, induces loss-of-function in channel activity and underlies SANDD. To date, only one variant c.1208_1209insGGG:p.(G403_V404insG) has been reported for SANDD syndrome. We studied five Pakistani families with SANDD and characterized a new missense variant p.(A376V) in CACNA1D in one family, and further characterized the founder variant p.(G403_V404insG) in four additional pedigrees. We show that affected individuals in the four families which segregate p.(G403_V404insG) share a 1.03 MB haplotype on 3p21.1 suggesting they share a common distant ancestor. In conclusion, we identified new and known variants in CACNA1D in five Pakistani families with SANDD. This study is of clinical importance as the CACNA1D founder variant is only observed in families from the Khyber Pakhtunkhwa (KPK) province, in Pakistan. Therefore, screening patients with congenital deafness for SAN dysfunction in this province could ensure adequate follow-up and prevent cardiac failure associated with SAN.
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Introduction
Deafness is a common sensory impairment which effects almost 278 million people worldwide [1] . Genetic deafness is very heterogeneous and can be syndromic (30% of cases) or non-syndromic (70% of cases). Several syndromes are associated with deafness and heart anomalies, but only two syndromes with deafness and heart problems as the sole features have been described: Jervell and Lange-Nielsen syndrome (JLNS) and Sinoatrial node dysfunction and deafness (SANDD) syndrome (OMIM 614896). KCNQ1 and KCNE1 are associated with the JLNS. Both genes encode potassium channels found in the heart and stria vascularis of the cochlea. SANDD syndrome, characterized by sinoatrial node dysfunction and deafness, was previously reported to be due to an insertion of one glycine residue (c.1208_1209insGGG) in the CACNA1D gene (rs398122827) [2] and no additional variants have been reported.
CACNA1D is an important gene for inner ear cells that encodes the pore-forming α 1D subunit (Ca v 1.3) of L-type voltage-dependent calcium channels (LTCCs). These channels tightly control Ca 2+ -dependent glutamate release in the cochlear inner hair cell (IHC) ribbon synapses and are essential for hearing [3] . LTCCs are multisubunit complexes, consisting of alpha-1, alpha-2, beta, and delta subunits. The channel activity is directed by the pore-forming and voltage-sensitive alpha-1D subunit [4] . α1 is a transmembrane domain composed of four homologous domains (D1-D4) each containing six α-helices (S1-S6). S5 and S6 along with linker peptide (S5-S6 linker) form the pore of voltage-dependent calcium channel [5] . These channels have been found to play a role in heart and smooth muscle contraction and in the transmission of auditory information. Ca v 1.3 is largely absent from the ventricles but is highly expressed in atria and sinoatrial node (SAN) [4] . In the ear, Cav1.3 channels are located at IHC synapses and they mediate Ca 2+ influx which is required for transmission of auditory information into the brain via the auditory nerve. LTCCs containing a pore-forming α1D subunit (D-LTCCs) are essential for normal cardiac pacemaking. Loss-offunction of Ca v 1.3 channels also induces SAN bradycardia in mice [3] . Several cardiac disorders such as sinus bradycardia and tachycardia, sinus arrest, sinus-exit, block and alternating periods of bradycardia, and tachycardia are considered as signs of sinus dysfunction [6] . As there is an important role of Ca v 1.3 in the heart and central auditory system, it is not surprising that CACNA1D causes a phenotype in both systems [7] .
To date, only one variant has been reported for SANDD syndrome which segregated in two separate families. The homozygous CACNA1D c.1208_1209insGGG variant was first described in SANDD individuals in two Pakistani consanguineous families from the KPK province (personal communication with Dr. Shahid Mahmood Baig). It was previously suggested that this variant is possibly a founder mutation [2] .
In this study, we describe an additional four families from the KPK province with this same variant in CACNA1D (c.1208_1209insGGG), provide more information on its founder origin, and also characterized a new SANDD syndrome missense variant in CACNA1D in a family also from the same province. If a cardiac dysfunction remains clinically silent in these patients, it can have fatal consequences. Cardiac investigation is therefore highly recommended for individuals with deafness of unknown genetic origin in the KPK province of Pakistan. To avoid the cardiovascular complications, a regular follow-up of individuals with SANDD syndrome is highly recommended. The present study broadens the variant spectrum of SANDD and it also supports that CACNA1D is the causative gene for SANDD.
Methods
Sample collection
This study was approved by the Institutional Review Boards of the Quaid-i-Azam University and the Baylor College of Medicine and Affiliated Hospitals. Written informed consent was obtained from all participating members.
Five unrelated consanguineous families DEM4730, DEM4713, DEM4690, DEM4591, and DEM4318 ( Fig. 1 ) with deafness and cardiac dysfunction were enrolled from different areas of the KPK province. All families displayed an autosomal recessive mode of inheritance for SANDD. Affected members of these families underwent a complete physical examination. Electrocardiograms (ECG) and puretone audiometry were performed at a local government hospital.
Whole-genome genotyping and linkage analysis
Genomic DNA was extracted from peripheral blood using a phenol chloroform procedure [8] . Whole-genome genotyping was performed for all samples using the Illumina Human Core SNP array, which contains~250,000 singlenucleotide polymorphisms (SNPs), for families DEM4730, DEM4713, and DEM4690, and the Illumina linkage panel bead array, which includes 6000 SNP markers for families DEM4591 and DEM4318. We performed two-point and multipoint linkage analyses using Merlin [9] assuming an autosomal recessive mode of inheritance with complete penetrance, no-phenocopies, and a disease frequency of 0.001. Marker allele frequencies were estimated from the founders and reconstructed founders who were genotyped at the same time while the genetic map positions (cM) were interpolated using the Rutgers Combined Linkage-Physical map. Homozygosity mapping was also performed to analyze the genotype data using Homozygosity Mapper [10] .
Exome sequencing
Exome sequencing was performed using a DNA sample from an affected family member from each family: DEM4730 (IV:2); DEM4713 (IV:1); DEM4690 (IV:1); DEM4591 (V:3); and DEM4318 (IV:2) ( Fig. 1a-e) . Roche NimbleGen SeqCap EZ Human Exome Library preparation kit v.2.0 was used, which selects~37 Mb of sequence target. Sequencing was performed by 70 bp paired-end sequencing on a HiSeq2500/4000 instrument (Illumina Inc, San Diego, CA, USA). Reads were aligned to the Human genome (hg19/GRC37) using the Burrows-Wheeler algorithm [11] and duplicates were removed with Picard (GATKIndelRealigner). Single-nucleotides variants (SNVs) and small insertions/deletions (Indels) were called using GATK [12] and annotated using dbNSFP and ANNOVAR to aid in filtering and interpretation [13, 14] .
Filtering was performed for each exome and only frameshift, in-frame indels, non-synonymous, start/stop altering, nonsense, splice-site variants with a minor allele frequency (MAF) < 0.005 in every Genome Aggregation Database (gnomAD) population were retained. Variants conservation scores (e.g., PhastCons, GERP) [14] and Combined Annotation Dependent Depletion (CADD) Cscores [15] were assessed prior to testing for segregation within the pedigrees. Homozygous variants meeting these criteria in mapped linkage intervals and regions of homozygosity were given priority. Below each family member of DEM4730 for which a DNA sample is available, their CACNA1D c.1127 C > T genotype is shown. For DEM4713, DEM4690, DEM4591, and DEM4318, the CACNA1D c.1208_1209insGGG genotype is shown for family members from whom a DNA sample is available
Sanger sequencing
Segregation of variants of interest were verified with Sanger sequencing in the five consanguineous families. Primers surrounding region of interest were designed using primer3 software [16] . PCR amplified products were purified with the ExoSAP-IT™ PCR Product Cleanup Reagent and sequenced using the BigDye terminator v3.1 cycle sequencing kit (on an ABI 3130 Genetic Analyzer).
Haplotype analysis
A founder haplotype was constructed by comparing the genotypes of affected family members of DEM4713 IV:1, DEM4591 V:3, DEM4690 IV:1, and DEM4318 IV:2 who are carriers of the c.1208_1209insGGG variant using the exome sequence data (Fig. 4) .
Three-dimensional modeling
The amino acid sequence of human voltage-dependent Ltype calcium channel subunit alpha-1D protein was obtained from the UniProt database [17] . The homology modeling techniques were utilized to construct the threedimensional (3D) model of CACNA1D from the atomic coordinates of Protein data Bank (PDB) entry 2ZXE using PyMOL program [18] . The UCSF Chimera Program was used for the visualization of protein structure [19] .
Results
Clinical presentation
Deafness was congenital and severe (71-95 dB) or profound (>95 dB) in all frequencies for all affected members of the SANDD families ( Fig. 2c; Supplementary Fig. 1 ). Individual IV:2 from family DEM4730 with new missense variant c.1127 C > T; p.(A376V) displayed congenital severe deafness affecting all frequencies. There were no obvious signs of vestibular dysfunction, but he did report the symptoms of fatigue, dizziness, and dyspnea. For this family, DEM4730, we were only able to record the ECG for affected family member IV:2 at the age of 15 years. We were unable to obtain ECG from his affected brother IV:3 because he was deceased at the time of the present study. Individual IV:2 displayed bradycardia in ECG recordings. His ECG waveform clearly mark regular but slow rhythm, narrow QRS complex, and P wave did not regularly precede the QRS complex. The recorded heart beat rate was 48 beats per minute (bpm) calculated from beat to beat R-R interval (Fig. 2b) . The control shows a normal ECG waveform and the heart beat rate was 60 bpm (Fig. 2a) . Individual IV:1 from family DEM4713 and IV:2 from DEM4690 also showed an abnormal pattern of ECG waveforms with bradycardia ( Supplementary Fig. 2 ). For the affected family members there were no additional symptoms, nor any other abnormalities observed.
Genotyping and exome sequencing
Linkage analysis and homozygosity mapping in these families identified several homozygous regions on different chromosomes. A homozygous region on chromosome 3p was shared by all families and the highest LOD score was also observed for each family to this region (Table 1) . A DNA sample from a single affected family member per family underwent exome sequencing.
In families DEM4713 (IV:1), DEM4690 (IV:1), DEM4591 (V:3), and DEM4318 (IV:2) the same variant in CACNA1D c.1208_1209insGGG: p.(G403_V404insG) was observed and for DEM4730 a missense variant, c.1127 C > T; p.(A376V) was identified in CACNA1D (NM_000720). DNA samples from all available family members underwent Sanger sequencing and the variants segregated in each respective family (Fig. 1a-e) .
The c.1127 C > T; p.(A376V) variant has a CADD Cscore of 32 is predicted damaging according to Mutation Taster, and is conserved amongst species (GERP++ RS 5.28 and PhyloP20way 0.852). In addition, the variant is not present in the Greater Middle East (GME) Variome Project ) ( Table 1 ). The variant was not observed in the homozygous state in gnomAD [21] . Sanger sequencing demonstrated the segregation of the homozygous missense variant (Fig. 3b) . This variant affects CACNA1D exon 8B (NM_000720), an alternatively spliced exon that is expressed in the IHCs and SAN cells [2] . The variant has been reported in ClinVar (rs759274321), but no peer-reviewed study has reported the clinical significance of this variant to date. The alanine at amino acid position 376 p.(A376V) is completely conserved among various species and other isoforms of LTCC α1 subunit (Fig. 3g) . This amino acid is found in the extracellular topological domain of the α 1D subunit (Ca v 1.3) of LTCCs (Fig. 3a) .
Haplotype analysis
Comparison of the genotypes surrounding the CACNA1D gene using exome data revealed that affected family members from DEM4713, DEM4690, DEM4591, and DEM4318 all shared a small 1.03 Mb haplotype from chr3:53326534-54354510 (hg19) at 3p21.1, suggesting that the in-frame variant c.1208_1209insGGG arose on a common founder haplotype (Fig. 4) . We confirmed that this variant is a founder mutation.
3D modeling
To investigate the possible effect of the p.(A376V) variant, 3D modeling was used to inspect putative structural changes caused by this variant. The residue Ala376 is present in the α-helix of third extracellular domain of protein. In the wild-type protein, the short Ala residue is not involved in any intermolecular interaction with the nearby residues. The variant adds a bulky hydrophobic side chain which contributes the hydrophobic interaction with the nearby residue Trp372 which possibly alters the electrostatic potential compared with wild-type (Fig. 3c-f) . severe-to-profound deafness [2] . In this study, we identified four additional families DEM4713, DEM4690, DEM4591, and DEM4318 with the same variant, c.1208_1209insGGG: p.(G403_V404insG). In an additional family DEM4730 we also identified a new missense variant c.1127 C > T:p. (A376V) (rs759274321) in exon 8B (NM_000720) of CACNA1D, which is predicted to be pathogenic. This SANDD variant has been reported as pathogenic in ClinVar but no peer-reviewed study has reported its clinical significance. This variant affects the alanine residue in the third extracellular loop, which is in close proximity to the sixth helical domain of CACNA1D where known variant c.1208_1209insGGG:p. (G403_404insG) is present (Fig. 3a) . The third extracellular domain is a pore loop which is present in D1 between the S5 (fifth helical domain) and S6 (sixth helical domain) of the α1 subunit. The pore loop acts as a linker between S5 and S6 (S5-S6 linker) (Fig. 3a) and forms the pore region along with S5 and S6 of the α1 subunit [22] . The S5-S6 linker of D1 has an important role in the conductance of calcium ions across the membrane [23] . 3D protein modeling of variant p.(A376V) shows a change in interaction within the protein due to the substitution of a Ala with Val at position 376 in the third extracellular domain (S5-S6 linker) (Fig. 3c-f) . Val376 leads to an additional hydrophobic interaction with Trp372 which is present in S5 (Fig. 3f) . This additional hydrophobic interaction could affect the shape of the inner part of the pore and influence the movement of calcium ions across the membrane.
We observed a slow heart beat rate along with severe-toprofound deafness in the SANDD-affected individuals ( Fig. 2b, c; Supplementary Figs. 1 and 2 ). The slow heart rate is possibly due to the defect in the Ca v 1.3 subunit. It is evident from the previous studies that Ca v 1.3 channels are involved in heart rate control in humans. Hence, sinoartrial node dysfunction slows down the pacemaking activity of the heart [2, 24] . Patients of SANDD have severe-toprofound deafness and sinus bradycardia. Similarly, homozygous knockout mice for CACNA1D exhibit deafness and heart defects [3] . The pleiotropic role of CACNA1D has already been established [7] . Ca v 1.3 channels could also be a potential drug target to control heart rate for disease conditions.
A recurrent variant that occurs in a single haplotype of a population can be considered a founder mutation, while a variant that occurs on more than one haplotype is considered a hot-spot mutation [25] . Four unrelated families in our study (DEM4713, DEM4690, DEM4591, and DEM4318) with the same variant c.1208_1209insGGG were recruited from the KPK province of Pakistan. We compared SNVs around the c.1208_1209insGGG variant, which indicated that these four families share the same haplotype for a very small region between chr3:53321631 and 54354510 (1.03 Mb) (Fig. 4) . The previously reported families with SANDD syndrome also share the same haplotype associated with the c.1208_1209insGGG founder mutation bounded by SNPs rs720625 and rs1526594 (corresponding to a genomic region of 9.1 Mb) [2] which overlaps with the haplotype observed in our four families.
Last, given this founder mutation was found in families from the same region and has been previously reported [2] , this suggests the founder mutation could be used for prenatal diagnosis in pregnancies where the parents are carriers. In addition, we recommend testing for cardiac problems in individuals with congenital hearing loss from the KPK province in Pakistan. This will ensure adequate follow-up and could prevent cardiac failure associated with SAN in the future. 
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